Type 2 diabetes mellitus study based on patient characteristics in Puskesmas Wiradesa
Keywords:
Diabetes mellitus type 2, Gender, Age, JobAbstract
Background: The Silent Killer is the name of diabetes mellitus because this disease has a major impact on the body's organs, causing various complaints in the body (Sarifah and Siyam, 2023). Diabetes mellitus (DM) is a chronic disease that occurs when the pancreas cannot produce enough insulin in the body so that the insulin produced in the body is ineffective. According to the Pekalongan Health Office, the highest prevalence of Wiradesa Health Center is 715 DM patients with various characteristics, namely age, gender, weight and occupation respectively. Objectives of the study: The purpose of this study was to assess Type 2 Diabetes Mellitus based on patient characteristics at the Wiradesa Health Center. Methods: Using analysis descriptive hod with secondary data on 715 samples of DM patients at Wiradesa Health Center. Results: The calculation results show that Type 2 DM cases are more prevalent in the 45-65 years age group with 510 patients (71.3%), females with 489 patients (68.4%), weighing around 51-70 kg with 405 patients (56.7%) with work status as housewives with 443 patients (62%). The average age was 57.92 ± 8.9 years and the average weight was 55.97 ± 9.9 kg. Conclusion: Based on the results of research data, type 2 DM patients mostly suffer from housewives aged 46-65. Prevention efforts include carrying out routines related to a healthy lifestyle, such as taking part in exercise or healthy walking and controlling food consumption patterns.
References
1. S. I. Oktora and D. B. Butar, “Determinants of Diabetes Mellitus Prevalence in Indonesia,” Kemas, vol. 18, no. 2, pp. 266–273, 2022, doi: 10.15294/kemas.v18i2.31880.
2. B. Prasetyo, “Type 2 Diabetes Mellitus: A Review of Determinants, Pathophysiology, Diagnostics, Management, and Complications,” JSRET (Journal of Scientific Research, Education, and Technology, vol. 4, p. 2025, 2025.
3. M. Vejendla, M. Anagani, and T. Oroszi, “Diabetes and Hypertension,” J. Diabetes Mellitus, vol. 15, no. 01, pp. 25–39, 2025, doi: 10.4236/jdm.2025.151002.
4. Kerekou Hode, A. H. Dedjan, and D.-G. Gnaho, “Prognostic Factors for Diabetic Foot at CNHU-HKM,” J. Diabetes Mellitus, vol. 14, no. 01, pp. 20–27, 2024, doi: 10.4236/jdm.2024.141003.
5. Md. M. Rahman et al., “Health Related Quality of Life in Adult with Type 2 Diabetes Mellitus,” J. Diabetes Mellitus, vol. 12, no. 04, pp. 243–251, 2022, doi: 10.4236/jdm.2022.124019.
6. S. Uzor et al., “Effect of Diabetes Mellitus on Male Reproductive Hormone of Diabetic Patients Attending Urology Unit of Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria,” J. Diabetes Mellitus, vol. 15, no. 01, pp. 59–70, 2025, doi: 10.4236/jdm.2025.151005.
7. S. A. Antar et al., “Diabetes Mellitus: Classification, Mediators, and Complications; A Gate to Identify Potential Targets for The Development of New Effective Treatments,” Biomedicine and Pharmacotherapy, vol. 168, Dec. 2023, doi: 10.1016/j.biopha.2023.115734.
8. L. Ismail, H. Materwala, and J. Al Kaabi, “Association of RiskFactors with Type 2 Diabetes: A Systematic Review,” Jan. 01, 2021, Elsevier B.V. doi: 10.1016/j.csbj.2021.03.003.
9. Pan et al., “Global Burden of Diabetes Mellitus 1990–2021: Epidemiological Trends, Geospatial Disparities, and Risk Factor Dynamics,” Front. Endocrinol. (Lausanne)., vol. 16, 2025, doi: 10.3389/fendo.2025.1596127.
10. L. Wang et al., “Associated Factors and Principal Pathophysiological Mechanisms of Type 2 Diabetes Mellitus,” Front. Endocrinol. (Lausanne)., vol. 16, 2025, doi: 10.3389/fendo.2025.1499565.
11. H. Liu et al., “Sleep Features and The Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis,” Ann. Med., vol. 57, no. 1, 2025, doi: 10.1080/07853890.2024.2447422.
12. F. Bah, A. R. Akotegnon, E. S. Baldé, M. S. Traoré, and B. M. Aliou, “Prevalence of Hypertension and Diabetes Sweet in Dubreka, in Guinea: A Cross-Sectional Study Exploring Modern and Traditional Healthcare Approaches,” J. Diabetes Mellitus, vol. 15, no. 01, pp. 1–24, 2025, doi: 10.4236/jdm.2025.151001.
13. Y. Chen, G. Wang, Z. Hou, X. Liu, S. Ma, and M. Jiang, “Comparative Diabetes Mellitus Burden Trends Across Global, Chinese, US, and Indian populations Using GBD 2021 Database,” Sci. Rep., vol. 15, no. 1, Dec. 2025, doi: 10.1038/s41598-025-96175-4.
A. Diawara et al., “Dyslipidemia in Adults with Type 2 Diabetes in a Rural Community in Ganadougou, Mali: A Cross-Sectional Study,” J. Diabetes Mellitus, vol. 14, no. 02, pp. 133–152, 2024, doi: 10.4236/jdm.2024.142012.
14. Syaripudin, A. Supardi, N. Ali Dahbul, R. H. S Rondonuwu, and P. Kesehatan Kementerian Kesehatan Manado, “Diabetes Melitus and Lifestyle Patterns in Society: A Comprehensive Literature Review,” International Journal of Science and Society, vol. 5, p. 2023, 2023, [Online]. Available: http://ijsoc.goacademica.com
15. X. Lu et al., “Type 2 Diabetes Mellitus in Adults: Pathogenesis, Prevention and Therapy,” Signal Transduct. Target. Ther., vol. 9, no. 1, Dec. 2024, doi: 10.1038/s41392-024-01951-9.
16. W. Soeatmadji, R. Rosandi, M. R. Saraswati, R. P. Sibarani, and W. O. Tarigan, “Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study,” J. ASEAN Fed. Endocr. Soc., vol. 38, no. 1, pp. 68–74, May 2023, doi: 10.15605/jafes.038.01.10.
17. Restika, A. Sulfikar, K. S. Wijayaningsih, and S. Tawil, “Long-Suffering of Diabetes Mellitus and Hospital Readmission among Adult with Type 2 Diabetes Mellitus : A Multicenter Study,” International Journal of Nursing and Health Services (IJNHS), vol. 6, no. 5, pp. 316–322, Oct. 2023, doi: 10.35654/ijnhs.v6i5.753.
18. Su, Y. Luo, S. Hu, L. Tang, and S. Ouyang, “Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents,” Int. J. Mol. Sci., vol. 24, no. 17, Sep. 2023, doi: 10.3390/ijms241713381.
19. Liu et al., “Clinical Metabolomics in Type 2 Diabetes Mellitus: from Pathogenesis to Biomarkers,” 2025, Frontiers Media SA. doi: 10.3389/fendo.2025.1501305.
20. R. J. Galindo, J. M. Trujillo, C. C. Low Wang, and R. G. McCoy, “Advances in The Management of Type 2 Diabetes in Adults,” Sep. 04, 2023, BMJ Publishing Group. doi: 10.1136/bmjmed-2022-000372.
Downloads
Published
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.